141 related articles for article (PubMed ID: 4588165)
1. Role of splenectomy in renal transplantation.
Bennett WM; Boileau M; Barry JM; Lawson RK; Hodges CV
Urology; 1973 Nov; 2(5):542-5. PubMed ID: 4588165
[No Abstract] [Full Text] [Related]
2. Prednisone used as treatment for rejection correlates with poor outcome.
Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
[No Abstract] [Full Text] [Related]
3. Antilymphocyte-serum preparations in treatment of renal-allograft rejection.
Mee AD; Evans DB
Lancet; 1970 Jul; 2(7662):16-9. PubMed ID: 4193750
[No Abstract] [Full Text] [Related]
4. Leukopenia and azathioprine management in renal homotransplantation.
Haesslein HC; Pierce JC; Lee HM; Hume DM
Surgery; 1972 Apr; 71(4):598-604. PubMed ID: 4553659
[No Abstract] [Full Text] [Related]
5. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
Siu CW; Chan TM; Li FK; Choy BY; Lui SL; Lo CY; Tang S; Lo WK; Lai KN
Transplant Proc; 2000 Nov; 32(7):1932-4. PubMed ID: 11120007
[No Abstract] [Full Text] [Related]
6. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
7. One-stage bilateral allotransplantation of canine lungs; further studies. Early rejection and prolonged survival with immunosuppression.
Kondo Y; Isin E; Cockrell JV; Hardy JD
J Thorac Cardiovasc Surg; 1972 Dec; 64(6):897-906. PubMed ID: 4564489
[No Abstract] [Full Text] [Related]
8. [Clinical picture of kidney transplantation. Surgical report].
Pichlmaier H
Langenbecks Arch Chir; 1968; 322():69-79. PubMed ID: 4098516
[No Abstract] [Full Text] [Related]
9. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
10. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
Mannick JA; Davis RC; Cooperband SR; Glasgow AH; Williams LF; Harrington JT; Cavallo T; Schmitt GW; Idelson BA; Olsson CA; Nabseth DC
N Engl J Med; 1971 May; 284(20):1109-15. PubMed ID: 4928659
[No Abstract] [Full Text] [Related]
11. [Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study].
Grundmann R; Wienand P; Meider G; Vlaho V; Pichlmaier H
Klin Wochenschr; 1984 Oct; 62(20):979-85. PubMed ID: 6389973
[TBL] [Abstract][Full Text] [Related]
12. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
13. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
[TBL] [Abstract][Full Text] [Related]
14. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone.
Bell PR; Briggs JD; Calman KC; Paton AM; Wood RF; Macpherson SG; Kyle K
Lancet; 1971 May; 1(7705):876-80. PubMed ID: 4102025
[No Abstract] [Full Text] [Related]
15. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
16. Immunosuppressive drugs used in clinical renal transplantation.
Chatterjee SN
Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
[No Abstract] [Full Text] [Related]
17. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
[No Abstract] [Full Text] [Related]
18. [The role of histocompatibility and antilymphocyte globulins in the early development of human renal homotransplantation].
Van Ypersele de Strihou ; Alexandre GP; Coche E; Sokal G
J Urol Nephrol (Paris); 1969 Sep; 75(9):608-15. PubMed ID: 4103961
[No Abstract] [Full Text] [Related]
19. [Evaluation of the effectiveness of ALG in clinical kidney transplantation in alternating studies].
Tidow G; Bunzendahl H; Wonigeit K; Pichlmayr R
Chir Forum Exp Klin Forsch; 1979; ():325-8. PubMed ID: 378593
[TBL] [Abstract][Full Text] [Related]
20. [Follow-ups after kidney transplantations].
Halbfass HJ; Staib I; Heinze V; Jontofsohn R; Junkers K
Dtsch Med Wochenschr; 1973 Mar; 98(10):479-81. PubMed ID: 4570868
[No Abstract] [Full Text] [Related]
[Next] [New Search]